Sakar Healthcare Limited (SAKAR) — Financial Results | 16 May 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Sakar Healthcare Limited announced the audio recording of its conference call for Q4FY26 held on May 15, 2026, to discuss audited financial results for the quarter and year ended March 31, 2026, now accessible on its website.

📄 View Original Announcement (PDF)

About Sakar Healthcare Limited (SAKAR)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,550.15 Cr P/E: 102.3

View full SAKAR stock details →

📡 Get AI alerts when SAKAR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAKAR — Free

📊 More SAKAR filings

See all SAKAR filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SAKAR files new disclosures

Track SAKAR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAKAR — Free

Free account · 2 AI queries/day